Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " August 03, 2011":" September 02, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events
Condition: HIV-Infection
Intervention: Other: Time of starting antiretroviral therapy
22 Completed Drug Interaction Study Between Dolutegravir and Prednisone
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir;   Drug: Prednisone
23 Completed A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: GSK1265744 injectable suspension;   Other: Placebo to match injectable suspension
24 Unknown  AIMS Study: Improving HIV Treatment Adherence
Condition: HIV
Interventions: Behavioral: Usual care;   Behavioral: AIMS counseling
25 Completed The Effect of Intermittent Rifampicin on Raltegravir
Conditions: HIV;   Tuberculosis
Interventions: Drug: Raltegravir;   Drug: Rifampicin
26 Completed
Has Results
Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy
Conditions: HIV;   AIDS;   Peripheral Neuropathy;   Pain;   Sleep
Interventions: Device: Splinting application to the lower extremities;   Device: Splint liner application
27 Completed Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth
Condition: HIV Prevention
Interventions: Behavioral: Integrated treatment program;   Behavioral: Treatment as Usual
28 Completed Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use
Condition: HIV Prevention
Interventions: Drug: Tenofovir 1% vaginal gel;   Drug: Depo-medroxyprogesterone acetate (DMPA);   Drug: Oral contraceptive: LNG 150 mcg and EE 30 mcg
29 Completed Improving Effective Contraceptive Use Among Opioid-maintained Women
Conditions: Contraceptive Usage;   Opioid Dependence
Interventions: Behavioral: Contraceptive management program;   Other: Usual care
30 Completed Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults
Condition: Vitamin D Deficiency
31 Completed
Has Results
Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate
Condition: HIV-1 Infection
Interventions: Drug: Niacin;   Drug: Aspirin;   Drug: Fenofibrate
32 Recruiting History of the KSHV Inflammatory Cytokine Syndrome (KICS)
Conditions: KSHV Inflammatory Cytokine Syndrome (KICS);   KSHV;   HHV-8
33 Completed
Has Results
Assessmet of Patients With PAH Right Ventricular Volume
Condition: Pulmonary Arterial Hypertension
Intervention: Device: Ventripoint Medical System
34 Terminated Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB Disease
Condition: Tuberculosis
Interventions: Biological: GSK Biologicals' investigational TB vaccine GSK 692342;   Biological: Placebo
35 Completed Assessing Preference for 3 Female Condoms: A Comparative Evaluation of the PATH Woman's Condom, FC2 and the Reddy 6
Condition: Contraception
Interventions: Device: Path Women's Condom;   Device: FC2 female condom;   Device: Reddy 6 female condom (V-Amour)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-35) Next Page   
Indicates status has not been verified in more than two years